NLRP3 and renal fibrosis: On one side, studies, such as those conducted by Wang et al., demonstrate that modulating the AMPK/mTORC1/NLRP3 signaling axis in diabetic kidneys can suppress NLRP3 inflammasome-mediated cellular death and mitigate renal fibrosis (38).